Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DAPAGLIFLOZIN PROPANEDIOL\METFORMIN: 2,236 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
2,236
Total FAERS Reports
175 (7.8%)
Deaths Reported
776
Hospitalizations
2,236
As Primary/Secondary Suspect
202
Life-Threatening
46
Disabilities

Active Ingredient: DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE ·

First Report: 1999 · Latest Report: 20250831

What Are the Most Common DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Side Effects?

#1 Most Reported
Diabetic ketoacidosis
176 reports (7.9%)
#2 Most Reported
Blood glucose increased
143 reports (6.4%)
#3 Most Reported
Nausea
124 reports (5.5%)

All DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Diabetic ketoacidosis 176 7.9% 2 125
Blood glucose increased 143 6.4% 1 31
Nausea 124 5.6% 0 51
Weight decreased 122 5.5% 3 22
Death 110 4.9% 110 10
Off label use 110 4.9% 3 28
Diarrhoea 103 4.6% 1 37
Ketoacidosis 96 4.3% 2 61
Vomiting 92 4.1% 4 49
Acute kidney injury 91 4.1% 4 75
Fatigue 77 3.4% 0 14
Metabolic acidosis 73 3.3% 5 63
Drug ineffective 72 3.2% 0 11
Dizziness 67 3.0% 0 11
Glycosylated haemoglobin increased 67 3.0% 0 9
Asthenia 59 2.6% 0 26
Urinary tract infection 59 2.6% 3 27
Malaise 57 2.6% 1 21
Euglycaemic diabetic ketoacidosis 54 2.4% 1 44
Abdominal pain 52 2.3% 0 23

Who Reports DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Side Effects? Age & Gender Data

Gender: 45.4% female, 54.6% male. Average age: 59.8 years. Most reports from: US. View detailed demographics →

Is DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2007 1 0 0
2008 3 0 1
2009 1 0 1
2011 1 0 0
2012 2 0 0
2014 9 0 3
2015 94 2 44
2016 122 3 64
2017 121 3 55
2018 108 5 44
2019 160 8 66
2020 146 11 68
2021 120 14 47
2022 106 18 45
2023 87 9 27
2024 111 9 63
2025 59 7 31

View full timeline →

What Is DAPAGLIFLOZIN PROPANEDIOL\METFORMIN Used For?

IndicationReports
Type 2 diabetes mellitus 831
Diabetes mellitus 509
Product used for unknown indication 99
Glucose tolerance impaired 18
Type 1 diabetes mellitus 17
Blood glucose abnormal 15
Blood glucose increased 15
Glycosylated haemoglobin increased 11
Weight decreased 11
Insulin-requiring type 2 diabetes mellitus 9

DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs Alternatives: Which Is Safer?

DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DAPRODUSTAT DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DAPSONE DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DAPTOMYCIN DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DARATUMUMAB DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DARATUMUMAB\HYALURONIDASE-FIHJ DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DARBEPOETIN ALFA DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DARIDOREXANT DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DARIFENACIN HYDROBROMIDE DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DAROLUTAMIDE DAPAGLIFLOZIN PROPANEDIOL\METFORMIN vs DARUNAVIR

Official FDA Label for DAPAGLIFLOZIN PROPANEDIOL\METFORMIN

Official prescribing information from the FDA-approved drug label.